Award
Delivery Order #SPE2DR26FP2FU
AmerisourceBergen Awarded Delivery Order for Dupixent Pharmaceuticals
Buyer
Defense Logistics Agency
Award Amount
$68,575.82
Ceiling
$68,575.82
Awarded
March 11, 2026
Period of Performance
Mar 11, 2026 – Mar 12, 2026
Identifier
SPE2DR26FP2FU
NAICS
424210
This award represents a delivery order contract under an existing indefinite delivery/indefinite quantity (IDV) agreement with AmerisourceBergen Drug Corp, a global leader in pharmaceutical sourcing and distribution. The contract procures Dupixent 300 MG/2 ML PEN, a critical pharmaceutical product used in treatment therapies. This delivery order ensures timely and reliable supply of essential medications, supporting the broader goals of healthcare service delivery and public health. The scope includes supplying specified doses of this medication to the designated location within a short-term performance window. Awarded under the parent IDV contract focused on pharmaceutical product distribution, this delivery order contributes to maintaining a steady, efficient pharmaceutical supply chain. The award was competitively facilitated as part of the parent contract's framework, emphasizing streamlined procurement and supply continuity. The performance period is set for a concise timeframe, indicating urgent or immediate need fulfillment aligned with ongoing agency requirements.
Description
4571116218!DUPIXENT 300 MG/2 ML PEN 2ML